Senza5 CART5

CD5-deleted chimeric antigen receptor T cells · Vittoria Biotherapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Senza5 CART5, covering 2025-11-10 to 2025-11-10. Get the full timeline:

Most recent: Clinical Trial Update: CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL) [Phase 1]